Vensana Capital is a venture capital and growth equity firm that invests in development- and commercial-stage companies across the medtech sector. Their strategy involves providing capital and partnership to entrepreneurs innovating in areas such as medical devices, diagnostics and data science, drug delivery, digital health, life-science tools, and tech-enabled services.
67% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals). Average disclosed round size is $26.9M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ventaris Surgical, Inc. | Series A | $30M | Jan 2026 |
 Okami Medical | Series B | $32.5M | Oct 2024 |
 Nyra Medical, Inc. | Series A | $20M | Nov 2022 |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
 Refined Laser Systems | Seed | $2.7M | — |
 Chowbus | Series A | $33M | — |
Top Co-Investors
U.S. Venture Partners3 shared
Broadview Ventures1 shared
New Leaf Venture Partners1 shared
DigiTx Partners1 shared
Cigna Ventures1 shared
APEX Ventures1 shared
NRW.BANK1 shared
Altos Ventures1 shared
Left Lane Capital1 shared
Hyde Park Angels1 shared
Fika Ventures1 shared
FJ Labs1 shared
Silicon Valley Bank1 shared
Longitude Capital1 shared
Atypical1 shared
Neotribe1 shared
Boutique Venture Partners1 shared
Last updated: 5 March 2026